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Abstract
Background: Vasculogenesis, the de novo formation of blood vessels from precursor cells is critical for a developing
embryo. However, the signals and events that dictate the formation of primary axial vessels remain poorly understood.
Methodology/Principal Findings: In this study, we use ets-related protein-1 (etsrp), which is essential for vascular
development, to analyze the early stages of vasculogenesis in zebrafish. We found etsrp
+ cells of the head, trunk and tail
follow distinct developmental sequences. Using a combination of genetic, molecular and chemical approaches, we
demonstrate that fli
+etsrp
+ hemato-vascular progenitors (FEVPs) are proliferating at the lateral plate mesoderm (LPM). The
Shh-VEGF-Notch-Hey2 signaling pathway controls the proliferation process, and experimental modulation of single
components of this pathway alters etsrp
+ cell numbers at the LPM.
Conclusions/Significance: This study for the first time defines factors controlling proliferation, and cell numbers of pre-
migratory FEVPs in zebrafish.
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Introduction
In vertebrate embryonic development the blood and endothelial
cells emerge side-by-side from a hypothesized common precursor
termed, ‘‘hemangioblast [1,2].’’ In zebrafish and xenopus, it has
been established that transcription factor fli1 is required for both
primitive and definite hemangioblast formation [3], and acts at the
top of the transcriptional network dictating blood and endothelial
cell development. Recently, in zebrafish, a transcription factor of
the ets family, ets1-related protein (etsrp) has been identified as a
key regulator of vasculogenesis [4]. Further, etsrp was shown to be
required for the formation of myeloid but not erythroid cells [5].
Both fli1 and etsrp are expressed at zebrafish trunk LPM at 10 som
when the putative angioblasts are specified from mesoderm cells,
and also at 26 som when the axial vessel is formed at the midline
[3,4]. Sufficient numbers of hemangioblasts or angioblasts are
necessary to generate a primary axial vessel. Cell proliferation is
one means of attaining the required cell number. However, in
zebrafish this mechanism has been considered unlikely to
contribute substantially to the precursor pool because of the short
temporal window in embryonic vasculogenesis (,7 hours), and
proliferation process especially of differentiated cells takes 16–24 h
for one cell cycle. Because fli1 acts at the top of the transcriptional
network driving blood and endothelial cell development, and is
sufficient to induce expression of key hemangioblast genes such as
etsrp [3], we hypothesized that fli
+etsrp
+ hemato-vascular progen-
itors (FEVPs) at the 10 som LPM proliferate prior to migration to
the midline. To investigate this hypothesis, we performed detailed
in situ hybridization (ISH) analysis for etsrp in zebrafish embryos of
early somite stages, and counted etsrp cells between 4 and 8 som
(,2 h window), which showed a two-fold increase in number of
cells. Next, we performed pulse chase, chemical treatment and
genetic mutant experiments to investigate whether FEVPs
proliferation occurred at the LPM. Classic bromodeoxyuridine
(BrdU) incorporation analysis, phospho-histone3 immunostaining
and hydroxyurea (HU) (S-phase inhibitor) treatment showed that
FEVPs are proliferating at the LPM. Further, we observed
reduced numbers of FEVPs in gridlock (grl) knockdown embryo,
which can partly be attributed to reduction in cyclin protein levels.
Grl/hey2, a Notch target gene was modulated by a variety of
approaches, which lead to the expected changes in FEVPs
numbers at the LPM. In vitro, grl knockdown (KD) in differentiated
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cycle. Finally, we determined that modulating each component of
the Shh-VEGF-Notch-Hey2 signaling axis results in altered
numbers of FEVPs indicating that these signals control precursor
cell number. Also, we present evidence suggesting that the
hypochord, a transient midline structure is the source of VEGF.
Together, this study identifies that the canonical Shh-VEGF-
Notch-Hey2 signaling axis as responsible for FEVPs behavior, and
generation of appropriate numbers through proliferation in a
developing vertebrate embryo.
Results
Distinct etsrp
+ cell behavior in head, trunk and tail of
embryonic zebrafish
To investigate vasculogenesis in vivo, we performed a detailed
ISH for ets1-related protein (etsrp), a marker for vascular and some
hematopoietic precursors in vertebrates [4]. We performed etsrp
ISH on embryos fixed at approximately every two hours in
development starting at 4 somites (som) until 30 hours post
fertilization (hpf) stage (Fig. 1). We noticed three distinct events in
the head, trunk and tail regions of the developing embryonic
zebrafish vasculature with two groups within the trunk zone.
First, in the head two lateral stripes of etsrp
+ cells (Fig. 1A, 4 som,
yellow asterisk) are connected in the anterior region with a bridge
of cells (Fig. 1A, 4 som). At 12 som, two populations of etsrp
+ cells
one from the anterior bridge (Fig. 1A, 8 or 12 som, green asterisk),
and another from the middle part of the lateral stripes (Fig. 1A, 12
som, white asterisk), showed an inward trajectory resulting in four
cephalic patches of etsrp
+ cells (Fig. 1A, 14 som, red arrows) at 14
som. The anterior most cells do not undergo substantial changes as
the embryo develops until 26 som, but cells in the posterior
patches become consolidated into a confined cluster, and
presumably contribute to the head vasculature.
Second, in the trunk (Figs. 1B-C, 4 and 8 som), we noticed two
lateral stripes of etsrp
+ cells evenly distributed on either side of the
midline. At 8 som, an asymmetric break is noticed (Fig. 1B, 8 som,
blue asterisk) in the cells of the LPM resulting in two etsrp
+ cell
populations that show distinct behavior. The anterior etsrp
+ cells
are present at medial position, but the posterior etsrp
+ cells are in
lateral positions (Fig. 1B-C, 12 and 14 som, compare green arrow
to yellow arrow). Beginning at 12 som, right at the time when the
head populations showed inward trajectory (Fig. 1A, 12 som), an
inner population (Figs. 1B-C, 12 and 14 som, pink arrows) of etsrp
+
cells arose in the trunk region. These cells are closer to the midline
than the lateral etsrp
+ cells in 8 som, and are also observed in the
region where axial vessels are forming (Fig. 1B-C, 12 and 14 som,
pink arrows). At 18–20 som, the anterior trunk and the midline
etsrp
+ cells come together (Fig. 1B-C, 18 som and 20 som, arrows)
at the site of future lateral dorsal aorta (DA). Over the course of
next few hours in development, the posterior trunk etsrp
+ cells
eventually disappear (Fig. 1D, 14–18 som, green arrows). Residual
etsrp
+ expression remains at prim-6 (Fig. 1B, prim-6, yellow arrows)
and 30 hpf.
In the tail tip region, a third population of etsrp
+ cells (Fig. 1D,
16 and 18 som, asterisk) gathers, which occurs around 16–18 som
Figure 1. Etsrp Whole Mount In Situ Hybridization. A montage of different embryonic stages starting from 4 som to 30 hpf was captured of
DIG-labeled etsrp antisense ISH whole mount embryos. Embryonic stages are described in somites (som) or hours post fertilization (hpf). A, head; B,
dorsal; C, trunk; D, tail; E, lateral; F, between head and dorsal view.
doi:10.1371/journal.pone.0014732.g001
FEVP Proliferation at LPM
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e14732stages. It is noteworthy that the trunk etsrp
+ populations (Fig. 1C,
14 som, pink arrow) observed at the midline in 14 som are
improperly assembled at the midline, and at this time point the tail
populations are not congregated at the tip as observed in later time
points of 16 and 18 som (Fig. 1D, 16 and 18 som, pink and green
arrows). At 18 som, when the tail etsrp
+ populations are aggregated,
the etsrp
+ cells at midline appear to properly assemble in a linear
fashion along the anterior-posterior axis, the future site of axial
vessels. At prim-6 (Fig. 1, prim-6, yellow arrow) and 30 hpf (Fig. 1,
30 hpf, yellow arrow), we notice remnants of the tail etsrp
+
population (Fig. 1, prim-6 and 30 hpf, asterisks). Lateral and
dorsal views of the entire process are captured in Figs. 1E and 1F
respectively. The dorsal view also illustrates that the head and
trunk etsrp
+ population do not fuse throughout development.
Starting at 26 som (Fig. 1D, 26 som) and progressing towards
prim-6 (Fig. 1D, prim-6), we noticed a gradual loss of etsrp
+
marker, perhaps associated with differentiation of the etsrp
+
lineage.
FEVPs proliferate at the LPM and midline
The observations on embryonic expression of etsrp suggest that
etsrp
+ cells in the head, trunk and tail zones show distinct and
coordinated behaviors. We furthermore noted a sizeable increase
in etsrp
+ cell numbers in between 4 and 12 som (Fig. 2A-C). To
quantify this observation, we counted the number of etsrp
+ cells at 4
and 8 som (Figs. 2A & B, inset red dots). These counts showed a 2-
fold increase (Fig. 2D, red bar) in absolute numbers of etsrp
+ cells.
We further quantitated whole embryo etsrp mRNA level using
Figure 2. FEVPs proliferate at the LPM. A to C shows dorsal view of etsrp
+ cells at 4, 8, and 12 som. Two lateral stripes of etsrp
+ cells evenly
distributed on either side of the midline at 4s (A). At 8 som, an asymmetric break is noticed (B, blue asterisks) in the cells of LPM resulting in two etsrp
+
cell populations that show distinct behavior (B and C, green and yellow arrows). A and B contain insets of etsrp
+ cells at LPM marked by red dots,
which was quantified in panel D, red bars. (D) show quantitation of etsrp
+ cells as indicated by red dots in panel (B) across each stage indicated in the
graph. Error bars represent SEM (qPCR, n=9; cell count, n=10). Red bars indicate absolute cell number and blue bars indicate etsrp transcript fold
change. Samples for analysis were collected at the indicated stages. (E-G) Developing embryos (1 som) were treated with BrdU (10 mM) in embryonic
buffer, and subsequent staining was performed with DAB substrate. The BrdU incorporated cells appear in the developing somites at the midline
(black arrows) and in the two lateral stripes of etsrp
+ cells at the LPM (red arrows) in E, F, and G. We confirmed the identity of BrdU
+ cell at 10 som by
ISH with etsrp AS probe (H), immunostaining of GFP in Tg(fli1a:nEGFP) embryos (I) and EdU incorporation assay (J) post 10 mm cross-section of the
embryos at 10 som. White arrows in J show EdU
+ cells at 10 som. (K) and (L) shows double immunostaining sections of Tg(fli1a:EGFP) 10 som embryos
stained for EGFP (green), and phospho-histone H3 antibody (p-H3, red). Arrows indicate merged yellow cells stained for both markers. Blue color is
from DAPI staining. Cartoon of 10 som embryos with different section plains for panels H-L are indicated.
doi:10.1371/journal.pone.0014732.g002
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etsrp
+ levels in the embryo (Fig. 2D, blue bar). To examine if the
developmental increase in etsrp
+ pools requires proliferation, we
performed bromodeoxyuridine (BrdU) incorporation assay to
detect cells undergoing DNA synthesis. Embryos incubated with
BrdU from 1 to 10 som showed robust BrdU incorporation at the
midline (Fig. 2E), and a weaker signal overlying the presumptive
LPM (red arrows, Figs. 2F and 2G). Developing somites serve as
an internal BrdU positive control at the midline (black arrow,
Fig. 2G).
Since Fli is upstream of etsrp in the transcriptional hierarchy, and
both participate in hematopoiesis and vascular development, we
refer to the population of cells in this study as Fli
+etsrp
+ hemato-
vascular progenitor cells (abbreviated as FEVPs). These cells are
vascular precursor populations, which retain some hematopoietic
potential. To identify the proliferating cells in LPM observed in 10
som embryos (Figs. 2F & 2G), we switched from BrdU to
fluorescent-conjugated ethynyl deoxyuridine (EdU) because it
provides the best option for efficient detection of incorporated
EdU. EdU allows for coupling reaction with fluorescent azide dyes,
and also allows for use of milder conditions (no DNA denaturation
process). We performed IF for green fluorescent protein (GFP)
(Fig. 2I) and fluorescent-conjugated EdU (Fig. 2J), incorporation [6]
on sections from 10 som transgenic embryos that carries friend
leukemia inhibitor (fli-1a) protein promoter driving nuclear
localized enhanced GFP (nEGFP) Tg(fli1a:nEGFP) [7] in the
vasculature. As shown in Fig. 2I, roughly 2–4 GFP
+ cells are visible
in the same location as etsrp
+ cells in the 10 som ISH embryos
(Fig. 2H). Importantly, 1–2 cells out of the GFP
+ population are
EdU
+ (Fig. 2J, white arrows) suggesting that a sub-population of
FEVPs were proliferative. To conclusively determine if the
proliferative cell was indeed an endothelial precursor cell, we
performed co-staining for phospho-histone H3 (p-H3) and GFP
protein in Tg(fli1a: EGFP) 10 som section (Fig. 2K). We confirmed
these results using double staining for p-H3 and GFP protein on the
same Tg(fli1a: EGFP) 10 som section (Fig. 2K-L, arrows).
Etsrp WISH observations, qPCR message and cell quantitation
measurements suggest a rapid increase in this precursor popula-
tion at the same time that multiple mitotic markers are detected on
Fli expressing vascular cells. Taken together, these data suggest
that FEVPs proliferate at the LPM.
Expression of the Shh-VEGF-Notch-Hey2 pathway
components is consistent with their action at LPM during
vasculogenesis
The sonic hedgehog (Shh)-VEGF-Notch-Hey2 signaling path-
way is well established for artery vs. vein (A/V) specification
during embryonic vascular development in vertebrates [8,9]. We
investigated whether this signaling pathway may be active during
vasculogenesis at the LPM. We first investigated whether
components of this pathway are expressed appropriately to
influence vascular development at the LPM. To determine
endogenous hey2/grl expression, we performed WISH study of grl
expression during embryonic zebrafish development (Figure S1).
Grl expression is observed only at the LPM as shown previously
[10], and at the midline (Figure S1). Notch1 and Notch4 are the
endothelial specific Notch [11]. In zebrafish, notch1b expression
was intriguingly similar to etsrp expression at 10 som in the LPM
[12]. ISH for endogenous shh (Figure S2A-F) showed that at bud
stage (Figure S2C & F) and 3 som (Figure S2B & E), diffuse
midline expression was observed, suggesting that presumptive
notochord cells express shh. At 10 som, shh was expressed in
midline notochord structures as shown (Figure S2A & D), and
demonstrated in previous reports [13]. ISH for vegf (both isoforms)
showed expression in somites and endoderm at 10 som (Figure
S2G, inset & H) [14]. IHC with VEGF antibody clearly showed
VEGF protein expression adjacent to hypochord in ventral
somites (Figure S2I, yellow arrow). Taken together, all compo-
nents of the Shh-VEGF-Notch-Hey2/grl pathway are expressed
temporally, and spatially at the LPM or in tissues adjoining it
during stages in which endothelial precursor cell numbers are
generated.
Gridlock (hey2) KD embryos show fewer FEVPs at the LPM
We next focused on addressing whether the Shh-VEGF-Notch-
hey2/grl pathway influenced the FEVPs population at the LPM,
beginning with the most downstream component, hey2/grl.
Using morpholinos (MOs) and a dominant negative approach,
we investigated whether FEVPs cell numbers were affected by loss
of grl/hey2 function. We first injected grl MOs into Tg(fli1a:EGFP)
embryos [15] and observed fli
+ cells at 16 som (Fig. 3A), and
found significantly fewer EGFP
+ cells compared to uninjected
embryos (Fig. 3B). Time-lapse photography of FEVPs migration
revealed fewer EGFP cells in the grl MO-injected embryo (Movie
S2) comparison to uninjected embryos (Movie S1). We also
performed p-H3 IF in 10 som control MO (Fig. 3C9), grl MO
(Fig. 3D), and uninjected embryos (Fig. 3C). We observed no
difference in p-H3
+ cell numbers at the midline, but a decrease in
p-H3
+ cell number is noted at LPM suggesting that grl loss of
function selectively affects proliferation at the LPM (Fig. 3E).
We next interfered with grl expression using a dominant
negative Suppressor of Hairless DNA binding mutant [Su(H)
DBM]
construct, which interferes with endogenous Su(H) activity by
sequestering Notch intracellular domain (notchICD) without DNA
binding. [16]. Su(H)
DBM-injected embryos (Fig. 3G) showed fewer
etsrp
+ cells compared to control MO-injected embryos (Fig. 3F).
Taken together, these experiments argue that grl function affects
proliferation and numbers of FEVPs cells at the LPM.
Notch signaling pathway is critical for FEVPs cell
development at the LPM
We next investigated Notch, an upstream positive regulator of
Grl. Since loss of grl function resulted in fewer etsrp
+ cells, we
hypothesized that constitutive activation of Notch dependent
transcription by injecting notch-intracellular domain (notchICD) mRNA
should increase numbers of these cells. Indeed, notchICD mRNA-
injected (Fig. 3H) embryos showed more etsrp
+ cells compared to
control MO-injected embryos (Fig. 3F). Quantitative determina-
tion of etsrp transcript levels in notchICD mRNA-injected embryo
showed a 1.75 fold increase in etsrp transcript levels (Fig. 3I, NICD
panel). As expected, grl-MO and Su(H)
DBM-injected embryos
showed a 0.3 to 0.6 fold reduction compared to WT embryos
(Fig. 3I, blue bars). We also checked for changes in vascular
endothelial growth factor (vegf) (Fig. 3I, red bars), and a reference
transcript actin (Fig. 3I, green bars), and observed no changes in
the levels of these transcripts in treated embryos compared to
controls. Finally, we inhibited notch ICD generation by chemical
inhibition of c-secretases using DAPT. Compared to DMSO
treated embryos (Figs. 3J & 3M), DAPT-treated embryos from
10–14 hpf (Figs. 3K & 3N) showed an overall expansion of scl
+
cells, and decrease of etsrp
+ cells most prominently in the posterior
LPM resulting in a decreased gap between anterior and posterior
LPM (bracket region). Similar results were observed for scl
+ cells in
embryos treated with a second c-secretase inhibitor, WPE-III-
31C- [17] (Fig. 3L) suggesting that etsrp
+scl
+ double positive cells in
this region are sensitive to notch inhibition, which is consistent
with a recent study that shows co-expression of both markers in
this cell population [18]. The whole embryo images of c-secretase
FEVP Proliferation at LPM
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determine the consequence of notch inhibition, we performed ISH
for flk, an established marker for differentiated endothelial cells on
Su(H)
DBM-injected 16 som embryos and observed that flk
+ cells
were mispatterned at the midline (Fig. 3P) compared to control
MO-injected embryos (Fig. 3O) especially at the region where the
future LDA merge (Compare Figs. 3O & 3P, bracket) to form the
DA. These results suggest that loss of etsrp
+ cells at LPM at 10 som
results in defective patterning of DA.
To dissect the temporal requirement of Notch signaling
pathway in controlling etsrp cell numbers, we utilized the Notch
gain-of-function (GOF) transgenic embryo system in which a heat
shock-inducible hsp70:Gal4 transgene drives a Gal4-responsive
upstream activating sequence (UAS) UAS:notch1aICD allele [19].
Embryos were transferred to 40 uC for 30 min at 1 som, and
analyzed using etsrp ISH at 10 som. Heat-shock induced embryos
showed ectopic induction of etsrp
+ cells in head (Fig. 4A, yellow
asterisk), trunk (Fig. 4B) and tail (Fig. 4C) regions of the developing
embryo compared to age-matched Tg(hsp70:Gal4) sibling controls
(Figs. 4E-G). The induction is pronounced in the lateral view
(Figs. 4D & H, yellow asterisks). Collectively, these results argue
that the Notch signaling pathway is critically involved in several
steps of FEVPs cell development at LPM.
Shh and VEGF are both involved in increasing etsrp cell
numbers at LPM
We next investigated the final two upstream elements of the
signaling axis, shh and VEGF. We performed shh and VEGF GOF
experiments followed by etsrp ISH at 10 som. Shh overexpressing
embryos (Fig. 4J) showed an increasein etsrp
+ cellsatLPM compared
toage-matched controls(Fig. 4I). Weindividually injected VEGF165,
capableofheparinbinding[20,21],andVEGF121 mRNA,incapable
ofheparinbinding [22] into 1-cell embryos. Both VEGF165 (Fig. 4K)
and VEGF121 (Fig. 4L) overexpressing embryos showed increased
etsrp
+ cells relative to controls, but distinct cell populations are
affected by the different isoforms. To confirm the embryos stages of
the injectedembryos,anISHforsomitemarkermyodwasperformed,
and is shown in Figure S3A-F (dorsal views), Figure S3G-L (lateral
views). VEGF165 overexpression (Fig. 4K) resulted in increased
numbers in the outer row of cells of trunk LPM, while in case of
VEGF121 (Fig. 4L, asterisk), the inner row of cells is increased. The
lateral views (Figs. 4I9-L9) show more pronounced etsrp cell migration
defects in VEGF GOF embryos.
To explore if temporal and spatial availability of VEGF
influenced angioblast numbers at the midline, we injected deltaA
(dlA) (a zebrafish delta homologue/notch ligand) mRNA into 1-cell
embryo. DlA mRNA has been shown previously to increase
floorplate and hypochord cells, sources of VEGF, at the expense of
notochord [23]. DlA mRNA-injected embryos showed expected
increase in col2a1 expression (data not shown), a marker of
floorplate and hypochord cells. In dlA mRNA-injected embryos,
we noticed a distinct increase (Figure S4G-I) of etsrp
+ cells
compared to control uninjected embryos (Figure S3D-F). We also
performed western blots for VEGF protein levels in dlA mRNA, grl
MO and uninjected embryos from 10 som lysates (Fig. 5A). We
found that dlA mRNA injected embryos showed a slight increase
(Fig. 5A, Table) in the faster migrating VEGF121 isoform, while grl
MO showed a decrease in VEGF121 isoform (Fig. 5A, lower band
missing, asterisk) compared to uninjected embryos. Interestingly,
the QPCR data in Fig. 3I showed no change in total vegf mRNA
(both isoforms) in embryos injected with grl MO, while the western
blot in Fig. 5A shows changes in VEGF121 protein isoform. This
suggests that increased stability or presence of vegf165 mRNA
isoform compensates for loss of vegf121 mRNA in those embryos.
Taking the grl/hey2, Notch, VEGF and Shh data together, it
implies that the Shh-VEGF-Notch-Hey2 signaling pathway
temporally and spatially regulates etsrp
+ cell proliferation during
embryonic vascular development.
Grl/hey2 participation in proliferation process in
differentiated endothelial cells in vitro is minimal
To investigate loss-of-grl/hey2 function in vitro, we designed small
interfering (siRNA) using the dicer method [24]. Efficacy of hey2
siRNA was demonstrated by RT-PCR for hey2 gene, and showed
targeting when compared to control (lacZ) siRNA-transfected cells
(Figure S5, hey2 gel). We investigated proliferation of hey2 silenced
ECs initially using human pulmonary artery ECs (HPAECs)
because Hey2 functions in artery development [25]. Because
HPAECs were difficult to contact inhibit, subsequent cell cycle
analysis using FACS was performed on a synchronous population
of human umbilical vein endothelial cells (HUVECs). When
HUVECs were released from contact inhibition (CI), a robust
increase from 4.3 to 21.7% was noticed in S-phase (Figure S5, red
bar, CI to CR) along with a concomitant reduction in G0/G1
phase (82.1 to 62.8%, blue bar, CI to CR). In hey2 siRNA
transfected HUVECs (Figure S5, hey2), we noticed an increase in
G0/G1 phase (73.3%) compared to lacZ siRNA transfected
HUVECs (68.6%) and a concomitant decrease in S-phase cells
(16.2%-hey2 siRNA, 17.1%-lacZ siRNA). However, statistical
analysis showed no significance of this difference across samples.
Figure 3. Notch signaling pathway plays a role in FEVPs proliferation at the LPM. Loss of grl function by morpholino injection is shown in
panels (A) to (D). Panels (A) and (D) are grl MO injected, panels (B) and (C) are uninjected fish, and panel C9 is control MO injected fish. In panels (A)
and (B), still images of Tg(fli1a:EGFP) grl-MO injected (A) or (B) uninjected Tg(fli1a:EGFP) 16 som embryos are shown. These images were part of a
series of images that were taken under a fluorescence microscope at every 10 min from 15 to 21 hpf, which was reconstituted to movie clips (Movie
S1 & S2). The grl-MO injected (A) clearly shows fewer fli
+ cells at 16 som. The same embryo group was also subjected to phospho-histone H3 antibody
staining at 10 som (C & D). E shows quantification of number of phospho-histone H3
+ cell at midline (C: center = inside 50 mm bar) in uninjected (UI,
dark blue bar), control MO (cont-MO, green bar), gridlock MO (grl MO, light blue bar), and in the same samples at LPM (P: periphery = outside 50 mm
bar). Error bars represent SEM (n=8). NS – not significant and ** p,0.001. (F-H) are control MO-injected, Su(H)DBM (a gridlock blocker) mRNA-injected
and notchICD mRNA injected embryos stained for etsrp at 10 som. The Su(H)DBM mRNA-injected embryo shows dramatic reduction of etsrp
+ cells at
10 som (F) while notchICD mRNA injected embryo (H) shows induction of etsrp
+ cells at 10 som compared to uninjected embryo (G). (I) qPCR analysis
showed that KD of grl by MO or dominant negative (Su(H)DBM) approach resulted in reduction of transcript level of etsrp but not vegf and actin (Error
bar is SEM, n=3, p,0.001). (J-N) Embryos treated with indicated chemicals from 10–14 hpf, subjected to whole mount ISH for scl and etsrp markers,
and flat mounted. (J-L) ISH for scl in posterior LPM of embryos treated with vehicle control DMSO (J) or the c –secretase inhibitors DAPT (K) or WPE-III-
31C [17] (L). Bracket indicates the midline convergence segment of the gamma loop of Gering et al. [54] The posterior scl expression domain is
thickened, and expanded anteriorly in embryos treated with c–secretase inhibitors. (M-N) ISH for etsrp in posterior LPM of embryos treated with
vehicle control DMSO (M) or DAPT (N). Etsrp expression domain is expanded anteriorly. (O-P) Dorsal view of Su(H)DBM mRNA- injected embryo at 16
som (P) showed dramatic mispatterning of flk
+ cells in trunk compared to that of uninjected embryo (O). (See also Figure S1 and Movies S1 and S2).
The numbers on the top right panel of all ISH embryos in this figure indicate number of embryos out of total number displaying that particular
phenotype.
doi:10.1371/journal.pone.0014732.g003
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distinct in endothelial precursor and venous differentiated
endothelial cells.
Grl/Hey2 affects cell cyclin protein levels in vivo, which is
reflected in cell phase specific inhibition by chemical
inhibitors
To investigate how Grl influences proliferation, we analyzed cell
cycle protein levels in zebrafish embryos. We investigated cyclin
B1, E and D1 protein levels in grl LOF and dlA GOF embryos at
10 som (Fig. 5B). Grl LOF represents loss of VEGF121 and dlA
mRNA injected embryos represent indirect gain of VEGF function
because it is known to increase floorplate and hypochord cells,
sources of VEGF. Compared to uninjected WT embryos, grl MO
embryos showed a decrease in cyclin B1 levels (Fig. 5B, red bar,
cyclin B1). In contrast dlA mRNA injected embryos showed an
increase in cyclin B1 levels (Fig. 5B, green bar, cyclin B1). Little
change in cyclin E or cyclin D1 is observed among sample groups.
We next investigated whether chemical inhibition of prolifer-
ation would reduce FEVP numbers at stages in which we observed
increased etsrp expression. Based on published literature for cell
cycle inhibitors in zebrafish [26], we treated zebrafish embryos
Figure 4. Shh-VEGF-Notch-Hey2 signaling pathway regulates FEVPs proliferation at the LPM. Etsrp WISH was performed on
Tg(hsp70:gal4;uas:NICD) and Tg(uas:NICD) embryos. A-H shows etsrp
+ cells of Tg(hsp70:gal4;uas:NICD) and Tg(uas:NICD) embryos in head, dorsal, trunk,
and lateral. Temporal expression of NICD at 1 som resulted in induction of etsrp
+ cells at 10 som. I to L show dorsal view of etsrp
+ cells in uninjected (I),
shh (J), vegf165 (K) and vegf121 (L) mRNA-injected embryos in trunk at 10 som. I9-L9 show lateral view of the 10 som etsrp WISH embryos. Vegf165 mRNA
(K) injected embryo shows more etsrp
+ cells in outer line (yellow asterisk) and vegf121 mRNA (L) injected embryos in inner line (asterisk). (See Figure S2
and S3). The numbers on the top right panel of all ISH embryos in this figure indicate number of embryos out of total number displaying that
particular phenotype.
doi:10.1371/journal.pone.0014732.g004
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Olomoucine (G1/G2 inhibitor), Genistein (G2 inhibitor) and
Colchicine and Nocodazole (M phase inhibitors) at 90% epiboly-1
som and performed ISH for etsrp (Figure S6) at 10-12 som.
Treatment with HU resulted in fewer etsrp
+ cells at LPM (Fig. 5H
& 5I) and head (Fig. 5G, head, compare white circled area in 5C).
In addition, these embryos showed mispatterned etsrp cells,
suggestive of migration defects (Figs. 5H & I, dorsal & trunk,
compare white arrows in 5D & 5E). Roscovitine (Figure S6B),
Olomucine (Figure S6C) and Genistein (Figure S6D) treated
embryos were indistinguishable from controls. However, Colchi-
cine (Figure S6E) and Nocodazole (Figure S6F) treatment resulted
Figure 5. Cell cycle analysis in 10 som embryos. (A) Overexpression of deltaA mRNA and KD of grl shows complementary changes in protein
levels for VEGF121 at 10 som. (B) Western blot analysis using total protein from uninjected, grl MO, and deltaA mRNA-injected embryos showed
reduction of cyclin B1 in grl MO injected embryos, and slight induction of cyclin B1 in deltaA mRNA-injected embryos. No change was observed in
cyclin E and D1 levels in deltaA mRNA or grl MO-injected embryos. The graph shows quantitation of the western blots with error bars representing
SEM (n=2, p,0.005). (C-J) These panels compare hydroxyurea (HU)–treated (G-J) embryos to untreated embryos (C-F). Treatment of HU, cell cycle
inhibitor from 1 to 10 som embryos resulted in reduction of etsrp
+ cells at the LPM (G-J) at 12 som. In untreated embryos, normal etsrp expression
patterns were shown as four sets of etsrp
+ cells in head (C, circle), migrating (D and E, white arrows) and stationary (D and E, white lines) etsrp
+ cells in
dorsal and trunk. h, head; t, trunk; tl, tail in N. (See also Figure S4 and Figure S6). The numbers on the top right panel of all ISH embryos in this figure
indicate number of embryos out of total number displaying that particular phenotype.
doi:10.1371/journal.pone.0014732.g005
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+ cell populations in embryos. Taken
together, these results indicate that global inhibition of prolifer-
ation interferes with the increase in etsrp
+ cells observed in control
staged embryos, suggesting a requirement for proliferation in
generation of the appropriately sized FEVP pool.
Discussion
A recent flurry of publication emphasizes the anatomical and
developmental inter-relationship between hematopoietic and
vascular cells in vertebrates [28,29]. Recent studies have shown
that that endothelial cells can give rise to hematopoietic precursors
[28,29], and conversely, hematopoietic precursors (HSC) have
vascular potential [30]. The shared origin within the LPM for
blood and vascular precursors perhaps contributes to this
phenomenon [31,32]. Depending on context, precursor cell
populations with vascular and hematopoietic potential can be
referred to as hemangioblast or hemogenic endothelium [33].
Because fli1 is the most upstream transcription factor in the
hierarchy of factors that drive specification of blood and vascular
precursor pools [3], and Scl [34,35], and more recently etsrp [4,5]
transcription factors (downstream of fli1) operate in both
vasculogenic and hematopoietic lineages, we refer in this study
to fli
+etsrp
+ hemato-vascular progenitor cells (abbreviated as
FEVPs) as vascular precursor populations, retaining some hemato-
poietic potential. The identification of etsrp as a marker required
for vasculogenesis in zebrafish [4] and Xenopus [36], has allowed
the investigation of the early events in vasculogenesis in a
developing embryo. Here, we have taken advantage of this marker
analysis in developing embryonic vasculature in zebrafish.
In this study, we have demonstrated that FEVPs proliferate at
the LPM in vivo, and that cellular proliferation is critical for
generation of correct numbers of vascular precursors. Several
salient features can be surmised from this study. First, etsrp
+
populations in the head, trunk and tail follow distinct develop-
mental and morphogenetic programs in response to local cues.
Second, the Notch signaling pathway regulates FEVPs prolifera-
tion at the LPM both temporally and spatially revealing a novel
contribution for this pathway in addition to its previously
understood role in A/V specification. Third, hypochord/endo-
derm may be the critical tissue source for VEGF driving FEVPs
proliferation at the LPM. Finally, cell cycle protein levels are
altered in embryos where Notch signaling is attenuated, suggesting
a mechanistic basis for FEVPs proliferation at the LPM.
Etsrp expression provides an unprecedented window into the
early events of vasculogenesis, as etsrp
+ populations in distinct
regions of the embryo appear to respond to local cues in different
manners and generate a pattern that is specific for that region.
First, injection of different vegf mRNA isoforms vegf165 vs. vegf121
results in differential effects on etsrp
+ cells in the trunk and head.
Importantly, other groups [37] have reported similar observations
at a later time point (30 hpf). Second, HU-treated embryos
showed different outcomes in the head and trunk etsrp
+ cells. Thus
the major populations of etsrp
+ cells along the anterior-posterior
axis of the embryo show distinct developmental effects and
differential sensitivity to perturbations.
The Shh-VEGF-Notch-Hey2 signaling pathway has previously
been identified as a central player in embryonic vascular
development in zebrafish [14,38,39]. The expression patterns of
Shh-VEGF-Notch-Hey2 are consistent with a role in FEVPs
proliferation at the LPM. Shh expression is detected as early as
bud stage, and continues until 10 som in midline notochord
structure as shown by others [13] and us. Vegf expression in somite is
not seen until 10 som [14], and is observed along the intermediate
mesoderm between the LPM and midline at 18–20 som [40]. At 6
som, the vegf expression is located in regions adjacent to yolk, and is
likely emerging from the transient hypochord structure, which is in
close association with the notochord [41]. At 9–10 som, we
hypothesize that VEGF from the hypochord (VEGF121) diffuses
laterally and comes in contact with the LPM cells, which are
continuous with the endoderm at this time point. Consistent with
this interpretationis our vegf ISHand IF data at 10 som. In addition,
data in Xenopus where diffusible form of VEGF expressed by the
hypochord is responsible for angioblast migration [42], and the dlA
mRNA injected embryo showing more etsrp
+ cells at the LPM
support this hypothesis. Further, notch activation increases
hypochord cells at expense of floor plate cells in zebrafish [43],
thereby causing an increase in VEGF source at hypochord similar
to dlA, and thus explains the putative increase in FEVPs in
notchICD-injected and heat-shocked Tg(hsp70:Gal4;uas:nICD) em-
bryos. The flk
+ cells are alsofound at 10 som adjacent to vegf
+ cells at
the LPM [14] suggesting that VEGF-Flk interaction may induce
Notch-hey2 signaling cascade resulting in FEVPs proliferation at
the LPM. Indeed, of the duplicated Notch1 in zebrafish, notch1b
expression is intriguingly similar to etsrp expression at 10 som in the
zebrafish LPM [12] suggesting that Notch1b could transactivate
hey2promoter[44],andinduceaproliferative signalinFEVPsatthe
LPM. Importantly, our heat shock experiments indicate that
precocious activation of Notch at 1 som lead to enhanced etsrp
+
cell population at 10 som suggesting that pathway components are
already in place at the LPM as early as 5 som, assuming that it takes
1–2 h for the production of NotchICD. Finally, Notch target: hey2/
grl is expressed also at the LPM at 5 som [10] and 10 som indicating
that temporally and spatially the Shh-VEGF-Notch-Hey2 signaling
axis is likely involved in FEVPs proliferation at the LPM from 3–10
som. A model is presented (Fig. 6) to explain this pathway in the
context of FEVPs development from 3 som to 10 som.
Chemical genetic studies with two known c-secretase notch
pathway inhibitors show that scl
+etsrp
+ cell populations are sensitive
to notch inhibition thus expanding the junction gap between the
anterior and posterior LPMs. These data contradict the recent
report from Lee et al, which concluded that Notch signaling
functions as a cell-fate switch between endothelial and hemato-
poietic lineages. This group [45] treated embryos with DAPT at
10–14 hpf, and showed an increase in endothelial cells and
decrease in hematopoietic cells at 18–20 hpf. However, this work
has several limitations. The interval spanning the drug treatment
and final analysis encompass several discrete developmental events
at the LPM and midline (Fig. 1). Secondly, the majority of the
analysis in this study relies on absolute cell numbers taken from
confocal sections. It is clearly not possible to match the exact same
location of the section each time across different embryos. Thirdly,
taking the first two limitations together, observations comparing
absolute numbers from section to section for a process that is
undergoing dynamic changes in a 10 h window are necessarily
correlative. Our study used two distinct c-secretase inhibitor
treatments, and a host of distinct complementary manipulations to
conclude that Notch signaling is involved in proliferation of
vascular precursor cells. Combining present work with those
presented in Lee et al’s, we hypothesize that modulating Notch by
DAPT alters the absolute number of precursors at 12 som, thereby
changing the numbers of differentiated cells of the blood and
vascular lineage observed at 18 hpf. However, this scenario does
not account for the selective up regulation of one lineage over
another, which is unclear for now.
Although cell proliferation is one mechanism of increasing cell
numbers, a second mechanism of cell specification can also
achieve the same effect. In this alternate hypothesis, ‘‘newly speci-
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increased cell numbers of the vascular lineage.’’ At present, we
have no evidence to refute this hypothesis. However, the
hypothesis in itself does not refute the evidence that is provided
here, which shows that endothelial precursor (fli
+, etsrp
+) cells are
proliferating at the LPM. Therefore, although increased specifi-
cation vs. proliferation could be reasoned for increasing cell
numbers, there is clear evidence here that suggests that once a cell
is specified, i.e., fli
+etsrp
+ (FEVP), this cell undergoes proliferation.
Importantly, the Notch signaling pathway, which we imply here in
proliferation shows precedence for playing a functional role in
proliferation of midline cells in zebrafish [43], and in zebrafish
hematopoiesis [46]. Moreover, Notch also participates in cell
proliferation events in Drosophila eye [47–48] and wing
development [49]. The zebrafish notch study [43] in particular
is highly relevant because the authors convincingly show that
elevation of notch signaling caused expansion of hypochord at
expense of notochord without affecting floor plate cells, and notch
inhibition via DAPT caused loss of hypochord cells. They also
demonstrated that notch signaling is involved in the proliferation
of midline floor plate progenitors similar to FEVPs reported here.
Prior to the mid-blastula transition (MBT), cells of zebrafish
embryos cycle without G1 and G2 phases [50,51]. Duffy and
colleagues have reported that key cell cycle regulators involved in
S to M phase transition include ccnb1 (cyclin B1), ccnb2 (cyclin B2),
and ccne (cyclin E). Here, we identify that cyclin B1 levels are lower
in grl LOF 10 som embryos. Enhancement of VEGF production
(indirectly by DeltaA) gave the opposite result, which suggests that
VEGF-Hey2 signaling axis at 10 som is capable of controlling
FEVPs proliferation via modulating cyclin proteins.
This study demonstrates FEVP cell proliferation at the LPM in a
developing vertebrate embryo, and implicates the Shh-VEGF-
Notch-Hey2 signaling pathway in this process. Whether this
process, and the signaling pathway utilized to accomplish precursor
cell proliferation are conserved in mammalian development is not
known. The data presented here continues the theme of signaling
pathways redundantly utilized at multiple stages in a developing
embryo, as is often the case in embryonic development [52].
Materials and Methods
Zebrafish husbandry and Microinjection
All zebrafish studies were performed according to MCW animal
protocol guidelines under protocol # 312-06-2, which were
approved by the MCW Institutional Animal Care and Use
Committee (IACUC). WT TuAB, Tg(fli1a:EGFP) and Tg(fli1a:-
nEGFP) were obtained from ZFIN. All DNA templates were
linearized with appropriate enzymes and transcribed by mMes-
senger mMachine kit (Ambion). Microinjection was performed
according to previously established protocols [53]. Seventy-five
picograms of each capped mRNA were injected into 1-cell stage
embryos. Heat-shock experiment was performed on a clutch of
embryos from mating of adult Tg(uas:notch1a-intra) and
Tg(hsp70:gal4) by transferring embryos at 1 and 5 som to 37 uC
for 30 min in a water bath [46]. Subsequently, embryos were
cultured at 28.5 uC until 10 som, fixed with 4% PFA, followed by
etsrp ISH.
Whole mount in situ hybridization,
immunohistochemistry, and section
Whole mount in situ hybridization (WISH) was performed as
described previously [53]. Hybridized embryos were photo-
graphed using a Leica Stereomicroscope equipped with a
Qimaging camera and images assembled in Adobe Photoshop
CS3 Extended. For immunohistochemistry, Tg(fli1a:nEGFP) em-
bryo was fixed at 10 som and frozen in TFM. Microm HM 550
(Thermo Scientific, Inc.) was used to generate serial 10 mm cryo-
sections embedded in tissue freezing medium (TFM) (Triangle
Biomedical Science, Inc.), which was mounted onto glass slide.
Immunohistochemistry was performed with rabbit anti-GFP
antibody (Cell Signaling, #2555) as primary and goat anti-rabbit
IgG-HRP-conjugated as secondary (Cell Signaling, #7074). The
signal was detected using tyramide labeled fluorescein (NEN Life
Science Products, Inc.) followed by company’s protocol. For
phospho-histone3 immunostaining, Tg(fli1a:EGFP) embryos was
fixed at 10 som and processed as described above followed by
immunohistochemistry with rabbit anti-GFP antibody (Cell
Figure 6. A model depicting the Shh-VEGF-Notch-Hey2 pathway in LPM angioblast proliferation. This model is based on data from here
and from other groups [12,14,37,38,40,41,55]. Nomenclature for the various structures, molecules and cell types are indicated. Starting at 3 som, sonic
hedgehog (shh) or other signal from the notochord stimulate VEGF121 expression from adjoining hypochord, which is associated with endoderm cells
lining the yolk boundary. At 4–8 som, VEGF121 diffuses via intermediate mesoderm and contacts angioblast cells that are positive for etsrp and flk
marker. At 9 som, a second source of VEGF from somite is detected, which is likely induced by shh from Notochord. Whether the two sources of VEGF
have similar or different function is unknown. At approximately 10 som, the VEGF binding to its receptor (Flk?) triggers Notch activation at the LPM
[12], which results in activation of downstream target genes such as hey2/gridlock. We hypothesize that this signal activation triggers angioblast
proliferation at the LPM. A second feedback loop of hey2-VEGF between hey2 angioblast and VEGF in somite or in hypochord exists, but the temporal
and spatial function of this loop is yet to be determined. NO: notochord, NT: neural tube, S: somite.
doi:10.1371/journal.pone.0014732.g006
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(Sigma, H6409) as primary and anti-rabbit IgG-Alexa 488
(Invitrogen, A-21204) and anti-mouse IgG-cy3 (Jackson Immu-
noResearch, 715-165-151) conjugated as secondary. The Signals
were imaged by Observer Z1 inverted microscope (Carl Zeiss).
The details of additional methods used in this study are provided
in the supplemental text file (Text S1).
Statistical analysis
Statistical analysis was performed using the Student’s t-test with
Graph Pad Prism (GraphPad Software, La Jolla, CA) and
Microsoft Office Excel 2010 software package. All data are
presented as mean 6 SEM (n and p-value are provided in each
figure).
Supporting Information
Text S1. This file contains methods used in the study but not
described in the main text file.
Found at: doi:10.1371/journal.pone.0014732.s001 (0.06MBDOC)
Figure S1. A montage of grl whole mount ISH from 8 som to 18
som embryos is shown in panels A-D. A (head), B (trunk) and C
(tail) are dorsal views and D (full embryo) is lateral view. The grl
expression is observed at 10–12 som at the LPM. This expression
is however appears medial and not as lateral as etsrp marker. The
expression in the midline starts at 16 som and continues until 18
som. The grl expression resembles flk expression (data not shown)
at 17 som and the expression is also seen in axial vessels at this
stage.
Found at: doi:10.1371/journal.pone.0014732.s002 (1.48 MB TIF)
Figure S2. A-F are whole mount Shh ISH embryos at 10 som
(A, D), 3 som (B, E) and bud (C, F) embryonic stage with
expression noticed at midline in all stages. (A-C) is lateral view
and, (D-F) is dorsal view. (G-H) are whole mount vegf ISH at 10
som. Inset in G shows the vegf expression in endoderm (e)
adjoining the yolk and somite (s). I is immunostaining of 10 som
section for VEGF protein. Yellow arrow indicates hypochord
staining of VEGF protein.
Found at: doi:10.1371/journal.pone.0014732.s003 (2.06 MB TIF)
Figure S3. Whole mount ISH with myod probe was performed
in 10 som uninjected embryos (A, G) or embryos injected with
reagents that are indicated in the panels. A-F is dorsal whole
mount ISH view, and G-L is lateral whole mount ISH view.
Found at: doi:10.1371/journal.pone.0014732.s004 (1.24 MB TIF)
Figure S4. Whole mount ISH with etsrp AS probe was
performed in DMSO (A) and notch inhibitors (B: DAPT or C:
WPE-III-31C) embryos at 10 som. Images show the entire embryo
at lower magnification. Similarly, etsrp ISH embryos for
uninjected and deltaA mRNA-injected embryos are shown in
panels D-I. D to F shows etsrp+ angioblasts in uninjected, and G
to I shows induction of etsrp+ angioblasts in deltaA mRNA-
injected 12 som embryo in head, dorsal, and trunk.
Found at: doi:10.1371/journal.pone.0014732.s005 (2.58 MB TIF)
Figure S5. Cell cycle analysis of hey2 siRNA knockdown
HUVECs are shown in this figure. (A) RT-PCR for actin and
hey2 genes in control siRNA and hey2 siRNA transfected
HUVECs are shown. (B) In vitro cell cycle analysis comparisons
using synchronized populations of hey2 and lacZ siRNA
transfected HUVECs are depicted. KD of hey2 in HUVECS
resulted in G0/G1 arrest. The table shows the absolute numbers
with +/2 SD (n=3). Comparison across sample groups reflects no
statistical significance (NS). CI: contact inhibited, CR: contact
released.
Found at: doi:10.1371/journal.pone.0014732.s006 (0.67 MB TIF)
Figure S6. Chemical treated embryos at 1 som (10 hpf) were
subjected to etsrp ISH at 10 som. Doses and description of
inhibitors were based on previous studies in zebrafish [5]. (A) wild
type (WT) untreated embryo, (B) Roscovitine, (C) Olomoucine, (D)
Genistein, (E) Colchicine, and (F) Nocodazole treated embryo.
The cell cycle activity profile for each drug is indicated to the right
of each panel.
Found at: doi:10.1371/journal.pone.0014732.s007 (3.35 MB TIF)
Movie S1. Utilizing Tg(fli1a:EGFP) embryo and fluorescence
microscopy the migration of angioblasts from the LPM to the
midline was captured via time lapse imaging every 10 min from
15 hpf to 21 hpf. The images were reconstituted to AVI format
movie. Movies clips showing angioblast migration in uninjected
(movie 1) embryos were captured.
Found at: doi:10.1371/journal.pone.0014732.s008 (1.86 MB AVI)
Movie S2. Utilizing Tg(fli1a:EGFP) embryo and fluorescence
microscopy, the migration of angioblasts from the LPM to the
midline was captured via time lapse imaging every 10 min from
15 hpf to 21 hpf in grl knockdown embryos. The images were
reconstituted to AVI format movie. Movies clips showing
angioblast migration in grl-MO injected (movie 2) embryo were
captured. KD of grl resulted in much fewer angioblast at the LPM,
and mispatterned assembly at midline.
Found at: doi:10.1371/journal.pone.0014732.s009 (1.62 MB AVI)
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